Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Why Colgate-Palmolive Remains an Overlooked Dividend King

Colgate-Palmolive Company (NYSE:CL) is often overlooked when investors discuss established dividend stocks. Names such as Coca-Cola, Procter & Gamble, and Johnson & Johnson tend to dominate those conversations. Colgate has a track record that deserves to be mentioned alongside them. It is a Dividend King, with 63 consecutive years of dividend increases and uninterrupted dividend payments dating back to 1895.

There is a straightforward reason the stock does not get as much attention. Colgate is not growing at a rapid pace, and its dividend yield is not especially high. Investors have to look past those points to see what makes the company appealing. It has a durable consumer business, well-known brands, and a long record of returning cash to shareholders.

A Dividend Record That Speaks for Itself

Colgate-Palmolive Company (NYSE:CL) raised its quarterly dividend to $0.53 per share in 2026 from $0.52. That takes the annualized payout to $2.12 per share. The size of the increase is not the main story here. What stands out is how long the company has kept doing it. Colgate has raised its dividend for more than six decades and remains firmly in Dividend King territory.

The products themselves also give Colgate-Palmolive Company (NYSE:CL) some stability. Toothpaste, toothbrushes, personal care products, and pet food are everyday purchases. Even when consumers become more careful with their money, these are not the easiest items to cut. Colgate also remains a major player in oral care, with a 41.3% global toothpaste market share and a 32.7% share of the manual toothbrush market year to date in 2026.

For a dividend investor, that matters. The company is working with a customer base that needs its products on a regular basis, which helps keep demand relatively steady.

Q2 Earnings Show the Business Is Still Generating Cash

Colgate-Palmolive Company (NYSE:CL)’s latest earnings report adds some support to that dividend record. The second quarter was solid overall. Net sales increased 4.9% from a year earlier to $5.36 billion, while organic sales rose 2.4%. Base Business earnings per share climbed 8% to $0.99 from $0.92. Gross margin also improved, expanding by 140 basis points to 61.5%.

The GAAP numbers were less encouraging, with diluted EPS down 5% to $0.86. Looking beneath that figure gives a somewhat better picture. On a Base Business basis, operating profit, operating margin, net income, earnings per share and free cash flow all increased from a year earlier, according to management.

The cash flow numbers are especially important for the dividend. During the first six months of 2026, Colgate-Palmolive Company (NYSE:CL) generated $1.74 billion in operating cash flow, compared with $1.48 billion a year earlier. After $266 million in capital expenditures, free cash flow before dividends came to $1.48 billion, up from $1.25 billion in the same period of 2025.

The company paid $879 million in dividends during the first half of the year, leaving free cash flow well above the amount needed to cover the payout. That is an important detail. A long dividend streak looks good on paper, but ultimately the business needs to generate enough cash to keep funding it.

Why Investors May Be Missing Colgate

The problem for Colgate-Palmolive Company (NYSE:CL) is that there is not much of a headline-grabbing story around its dividend. At $2.12 a year, the dividend does not provide the kind of starting yield that attracts investors focused on high current income. Those looking for double-digit dividend growth or a much higher yield may simply have other stocks higher on their lists.

There is also no getting around the fact that Colgate is a mature business. Organic sales increased just 2.4% in the second quarter, while North American organic sales fell 3%. That is not the sort of growth that usually draws investors looking for the next fast-growing consumer name.

For income investors, though, a mature business can have its own advantages. Colgate-Palmolive Company (NYSE:CL) does not need to grow revenue at a breakneck pace to remain a useful dividend stock. Its established brands and global presence give it a large customer base and recurring demand.

Management also left its 2026 sales outlook unchanged. It now expects mid-single-digit Base Business EPS growth, compared with its previous expectation of low- to mid-single-digit growth.

A Quiet Dividend King Worth a Closer Look

Colgate-Palmolive Company (NYSE:CL) may not have the same profile as some of the better-known Dividend Kings, but its recent numbers give investors a reason to take a closer look. Operating cash flow and free cash flow both improved in the first half of 2026. That leaves the company in a good position to fund its dividend while continuing to invest in the business.

There are still things to watch. Growth remains modest, and the decline in North American organic sales is not something investors should ignore. At the same time, Colgate has everyday brands, recurring demand, and a dividend history that stretches back more than six decades. For investors who care more about consistency than rapid growth, that combination remains relevant.

Colgate may not be the first dividend stock investors think of, but its long record and improving cash flow make a strong case for giving the stock a closer look.

While we acknowledge the risk and potential of CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Western Union’s High Yield is Raising Dividend Cut Concerns and Realty Income Corporation (O)’s Monthly Dividend Makes it a Standout Income Stock

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.